Hem › Beta-talassemi › New York
Kliniska studier för Beta-talassemi i New York
5 studier för Beta-talassemi söker deltagare vid platser i New York.
Officiell studietext (engelska)
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
- New York Presbyterian Hospital, New York
RekryterarFas 2
Ålder 6 till 17 · Alla kön · Uppdaterad 10 juli 2026 · NCT04143724A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre
RekryterarFas 2
Ålder 2 till 50 · Alla kön · Uppdaterad 3 juni 2026 · NCT05736419Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
RekryterarFas 3
Ålder 12 till 35 · Alla kön · Uppdaterad 23 mars 2026 · NCT05477563AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- New York Medical College, Valhalla
RekryterarFas 2
1 Day – 30 Years · Alla kön · Uppdaterad 8 aug. 2025 · NCT04099966A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
- Cohen Children's Medical Center, New Hyde Park
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 11 feb. 2025 · NCT06271512Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.